FXTAS presents with upregulation of the cytokines IL12 and TNFα

Parkinsonism Relat Disord. 2021 Jan:82:117-120. doi: 10.1016/j.parkreldis.2020.11.026. Epub 2020 Nov 30.

Abstract

Introduction: Fragile X Tremor and Ataxia Syndrome is a progressive neurodegenerative disorder that develops in some FMR1 premutation carriers. The objective of this study is to characterize how cytokine levels are altered in the FXTAS brain.

Methods: Fresh frozen cerebellar tissue from FXTAS cases and controls was homogenized and analyzed for 12 different cytokines using a commercially available ELISA panel.

Results: Relative to controls, FXTAS cases showed large and significant increases in the cytokines IL-12 and TNFα. There were large but non-significant increases in the levels of IL-2, IL-8, and IL-10 in FXTAS cases. The cytokines IL-1A, IL-1B, IL-4 IL-6, IL-17A, IFNγ, and GM-CSF were not different between FXTAS and control subjects.

Conclusions: For the first time, we demonstrate an increase in the pro-inflammatory cytokines TNFα and IL-12 in the FXTAS brain, both of which are implicated in the pathogenesis of Multiple Sclerosis, another neurodegenerative disorder that predominantly consists of white matter disease.

Keywords: FMR1 gene; FXTAS; Neurodegeneration; Premutation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arachnoiditis / metabolism*
  • Ataxia / metabolism*
  • Autopsy
  • Cerebellum / metabolism*
  • Female
  • Fragile X Syndrome / metabolism*
  • Humans
  • Interleukin-12 Subunit p35 / metabolism*
  • Male
  • Middle Aged
  • Tremor / metabolism*
  • Tumor Necrosis Factor-alpha / metabolism*
  • Up-Regulation

Substances

  • IL12A protein, human
  • Interleukin-12 Subunit p35
  • TNF protein, human
  • Tumor Necrosis Factor-alpha

Supplementary concepts

  • Fragile X Tremor Ataxia Syndrome